Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > Prizes > Prize Recipients > Katalin Karikó

Katalin Karikó

2022 Vilcek Prize for Excellence in Biotechnology

Portrait of Katalin Karikó

Location

Philadelphia, PA

Title

Adjunct Professor of Neurosurgery, University of Pennsylvania; Senior Vice President, BioNTech SE

Area(s) of Research

Messenger RNA-based gene therapy; RNA-induced immune reactions; molecular bases of ischemic tolerance; treatment of brain ischemia

Education

University of Szeged (PhD);
Biological Research Centre of the Hungarian Academy of Sciences (postdoc);
Temple University (postdoc);
Uniformed Services University of the Health Sciences (postdoc)

Country of Birth

Hungary

Follow Katalin Karikó
Twitter Facebook LinkedIn
Links to learn more about Katalin Karikó's work
  • Penn Medicine

Tags
biochemistry biomedical science BioNTech biotechnology covid-19 Hungary immunology mRNA sars-cov2 University of Pennsylvania vilcek prize for excellence women in science women in stem
Share this page
Twitter Facebook LinkedIn

Portrait of Katalin Karikó

Dr. Katalin Karikó’s approach to research embodies the idea espoused by Thomas Edison: “Genius is one percent inspiration and ninety-nine percent perspiration.” Since 1990, Karikó has pushed the boundaries of possibility for the development of messenger RNA (mRNA) therapeutics. Her persistence paid off: Karikó’s discoveries led to the development of safe and effective mRNA vaccines—including those now being deployed in the global fight against the COVID-19 pandemic.

Born in Szolnok, Hungary, Karikó began her career in postdoctoral research at the Biological Research Centre of the Hungarian Academy of Sciences in Szeged. In 1985, she received a postdoctoral research fellowship at Temple University, and her family made the decision to immigrate to the United States.

A black and white photo of Katalin Karikó, wearing a lab coat, at the Szeged Biological Research Centre in 1980.
Katalin Karikó at the Szeged Biological Research Centre in 1980. Photo courtesy of Katalin Karikó

Karikó received a research assistant professorship at the University of Pennsylvania in 1989. Working with Dr. Elliot Barnathan, early experiments proved that scientists could introduce mRNA into cells to compel the production of the encoded human proteins. Karikó was confident that if scientists could engineer mRNA encoding therapeutic proteins and introduce those into the human body, they could treat many diseases. There were two stumbling blocks: The injection of synthetic mRNA into a host system triggered inflammatory immune response, and funders were hesitant to provide resources for the work.

Katalin Karikó working on a laptop at a desk.

In 2005, working with immunologist Dr. Drew Weissman, Karikó discovered that modified nucleosides in mRNA rendered it non-inflammatory, safe for medical use. The research caught the attention of biotechnology companies Moderna and BioNTech. In 2013, Karikó went to work for BioNTech, while continuing her research at the University of Pennsylvania.

When the genetic sequence of SARS-CoV-2 was published by Chinese scientists in January 2020, biotechnologists recognized that the coronavirus’ distinctive spike protein made it a perfect target for mRNA vaccine technologies. Within hours—using the tools built on three decades of Karikó’s research—BioNTech designed the first mRNA vaccine to combat COVID-19.

Katalin Karikó standing and leaning against a desk.

Awards and Accomplishments

  • Member, American Academy of Arts and Sciences (2021)
  • Council of Human Dignity Award, Hungary (2021)
  • Great Immigrants, Great Americans, Carnegie Corporation (2021)
  • Building the Foundation Award, Research!America Advocacy Awards (2021)
  • Princess of Asturias Award, Spain (2021)
  • Semmelweis Prize, Hungary (2021)
  • Széchenyi Prize, Hungary (2021)
  • Wilhelm Exner Medal, Austrian Trade Association (2021)
  • Reichstein medal, Swiss Academy of Pharmaceutical Sciences (2021)
  • Louisa Gross Horwitz Prize, Columbia University (2021)
  • Member, Academia Europaea, Biochemistry & Molecular Biology (2020)
  • Lewis S. Rosenstiel Award, Brandeis University (2020)
  • Member, NIH National Heart, Lung, and Blood Institute

Follow Katalin Karikó

Twitter Facebook LinkedIn
Tags
biochemistry biomedical science BioNTech biotechnology covid-19 Hungary immunology mRNA sars-cov2 University of Pennsylvania vilcek prize for excellence women in science women in stem
Share this page
Twitter Facebook LinkedIn

Related Prize Recipients

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Polina Anikeeva

Polina Anikeeva receives the Vilcek Prize for Creative Promise in Biomedical Science for developing novel engineering solutions that have advanced the field of neural engineering and enabled fine-grained analysis of brain function and animal behavior.
Portrait of Polina Anikeeva

Michaela Gack

Michaela Gack receives the Vilcek Prize for Creative Promise in Biomedical Science for uncovering molecular mechanisms by which the human immune system triggers antiviral defenses, and for identifying potential vaccine and drug targets for emerging infectious diseases.
Portrait of Michaela Gack

You may also be interested in

March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
September 7, 2021

Announcing the 2022 Vilcek Foundation Prizewinners

The Vilcek Foundation awards $600,000 in prizes to outstanding immigrant leaders in biomedical science and in dance.
June 8, 2021

Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

Dr. Katalin Karikó receives the 2022 Vilcek Prize for Excellence in Biotechnology.
Katalin Karikó sits in her home office dressed in a black blazer.

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation